- 25B-NBMD
- N-(2,3-Methylenedioxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine
- 2C-B-NBMD
- N-[(2H-1,3-Benzodioxol-4-yl)methyl]-2-(4-bromo-2,5-dimethoxyphenyl)ethan-1-amine
- N-(1,3-Benzodioxol-4-ylmethyl)-2-(4-bromo-2,5-dimethoxyphenyl)ethan-1-amine
Anon. JW, Personal communication of unpublished research 1 Dec 2011.
Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB. #2.8 NMR
Hansen, M; Jacobsen, SE; Plunkett, S; Liebscher, GE; McCorvy, JD; Bräuner-Osborne, H; Kristensen, JL. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists Bioorg. Med. Chem., 15 Jun 2015, 23 (14), 3933-3937. 305 kB. https://doi.org/10.1016/j.bmc.2014.12.011 #1a
Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #2d NMR
IÍsberg, V; Balle, T; Sander, T; Jørgensen, FS; Gloriam, DE. G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations J. Chem. Inf. Model., 28 Feb 2011, 51 (2), 315–225. 1.1 MB. https://doi.org/10.1021/ci100402f #25Br-NBMD